Key result
Low-dose dobutamine speckle-tracking echocardiography outperforms tissue Doppler for predicting myocardial viability with AUCs up to ~0.98.
Why the study?
While speckle-tracking echocardiography overcomes the technical limitations of tissue-Doppler imaging for measuring myocardial strain during dobutamine echocardiography, it required validation for predicting myocardial viability before revascularization.
Does dobutamine echocardiography using tissue-Doppler imaging and speckle-tracking echocardiography predict myocardial viability compared to SPECT?
Observational (n=50)
Single-blind
No
Does dobutamine echocardiography using tissue-Doppler imaging and speckle-tracking echocardiography predict myocardial viability compared to SPECT?
This study aims to validate speckle-tracking echocardiography during dobutamine stress for predicting myocardial viability compared to SPECT.
Answers are grounded in this paper and cite their sources.
May enhance viability assessment; hypothesis-generating and requires prospective outcome validation.
Background: The use of myocardial strain imaging (MSI) during dobutamine echocardiography (DbE) may facilitate the prediction of myocardial viability. Both tissue-Doppler imaging (TDI) and speckle-tracking echocardiography (STE) are used for myocardial strain measurement. While STE overcomes technical limitations of TDI, it needs validation for prediction of viability.Aim of the work: To determine the relative accuracy of TDI-based and STE-based measurements of myocardial strain and strain rate for the detection of myocardial viability before revascularization using SPECT imaging as agold standard.Methods: The study included 50 patients (34 males, 16 females; mean age 52±8 years) with ischemic heart disease and left ventricular systolic dysfunction; who were undergoing DbE and SPECT after nitrat potentiation for assessment of myocardial viability The patients were divided into two groups according to the result of SPECT study after nitrate potentiation into viable and non-viable myocardial segments for possibility of myocardial revascularization.TDI and STE were used to measure longitudinal peak systolic strain (longS) and peak systolic strain rate (SR) at rest and at low-dose dobutamine (LDD).Results: Of the 850 segments, 415 segments were non-viable (48.2 %) and 435 segments were viable (51.8%) according to SPECT with nitrate potentiation, non-viable myocardial segments had significantly lower peak systolic strain and peak longitudinal systolic strain rateat LDD by TDI (areas under the receiver operator characteristic curves of 0.75, 0.85 respectively).Non viable myocardial segments had significantly lower peak systolic strain and peak longitudinal systolic strain rate at LDD by STE (areas under the receiver operator characteristic curves of 0.90, 0.98 respectively).Conclusion: Strain and strain rate measurements with both TDI and STE at LDD echocardiography can predict myocardial viability.However, STE is more accurate than TDI when both are compared to SPECT results.
No takes yet. Share an insight, caveat, or question.
A 2016 study conducted an observational in Ischemic heart disease with left ventricular systolic dysfunction (n=50). Speckle-tracking echocardiography (STE) and Tissue Doppler Imaging (TDI) during low-dose dobutamine echocardiography vs. Tc-99m-Sestamibi SPECT after sublingual isosorbide dinitrate (5 mg) potentiation (viable vs. non-viable myocardial segments) was evaluated on Peak longitudinal systolic strain (%) by speckle-tracking echocardiography (STE) at low-dose dobutamine in viable vs. non-viable myocardial segments (AUC 0.90, p=<0.001). Speckle-tracking echocardiography at low-dose dobutamine outperformed tissue Doppler in predicting SPECT-defined myocardial viability, achieving AUCs of 0.90 for strain and 0.98 for strain rate.
Synapse has enriched 10 related papers. Consider them for comparative context: